Search Results 951-960 of 18616 for autoimmune hepatitis

  1. Rheumatology - Overview - Mayo Clinic

    Rheumatologists at Mayo Clinic work in a team environment to provide state-of-the-art diagnosis and treatment for autoimmune and inflammatory diseases that ...

  2. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

    ... auto-immune hepatitis, or previous grade 3-4 drug-related hepatitis. Patient ... NOTE: There is no requirement to screen patients for hepatitis B ...

  3. Publications - Sudhakar K. Venkatesh, M.D. - Mayo Clinic

    ... Liver Disease. Radiographics. 2024 Nov; 44 (11):e240209. View PubMed; Zulfiqar M, Sugi M, Venkatesh SK, Loh JT, Ludwig DR, Ballard DH, Jayasekera C, Pannala R ...

  4. Leflunomide (oral route) - Mayo Clinic

    Liver disease, severe—Should not be used in patients with these condition. Lung disease (eg, interstitial lung disease), history of—Use with caution. May ...

  5. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    ... liver disease, Primary sclerosing cholangitis, Cholangiocarcinoma, Portal ... Autoimmune hepatitis, Amyloidosis, Nonalcoholic steatohepatitis ...

  6. ATHN 11: A Study of Liver Transplantation Outcomes - Mayo Clinic

    Human immunodeficiency virus (HIV) infection accelerates liver disease progression in patients with hepatitis C virus (HCV) and could shorten survival of ...

  7. Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients - Mayo Clinic

    Any known or suspected active organ-threatening autoimmune disease, such as inflammatory bowel disease, autoimmune hepatitis, lupus, or pneumonitis, with ...

  8. High cholesterol in children: How is it treated? - Mayo Clinic

    Sometimes thyroid disease, liver disease, kidney disease or medications can cause high cholesterol in children. Your health care provider may suggest tests ...

  9. Publications - Joseph A. Murray, M.D. - Mayo Clinic

    ... autoimmune diseases. Scand J Gastroenterol. 2023 Jul-Dec; 58 (12):1398-1404 Epub 2023 July 06. View PubMed; Behl S, Khan MR, Ismail Y, Swantek C, Chen ZE ...

  10. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...